- Litigation / Dispute Resolution (40)
- Regulatory and compliance (31)
- Company/Commercial (23)
- Intellectual Property (23)
- Banking / Finance (15)
- Information Technology (15)
- Employment (14)
- Tax (13)
- Corporate (12)
- Media/Entertainment/Sport (12)
- Financial services (10)
- Healthcare (10)
- Funds (7)
- Crime (6)
- Business Tax (5)
- Pharma/Biotech (5)
- Privacy and reputation (5)
- Construction (4)
- Energy (4)
- Environment (4)
- Insolvency & restructuring (4)
- Insurance/reinsurance (4)
- Telecoms (4)
- Clinical/Medical Negligence (3)
- Commodities (3)
- Human Rights (3)
- Licensing/Gaming/Betting (3)
- Pensions (2)
- Personal tax / Trusts (2)
- Transport (Including aviation and shipping) (2)
- Agriculture (1)
- Competition/EU (1)
- Family (1)
- PPP/PFI/Commercial projects (1)
- Professional Indemnity/Negligence (1)
- Public Sector/Local Authority (1)
- Real Estate (1)
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
A well-known British performing artist was granted permission to take his case to the Supreme Court, where he will appeal the Court of Appeal’s decision in OPO v MLA & STL.
The increased focus of national data protection authorities on the processing of personal data through mobile apps was again confirmed in an open letter from a group of data protection authorities.
Global Insight — Spanish insolvency laws; retention of title in the UK; portfolio transactions; and more
Global Insight is a digital publication bringing you news, views and analysis from DLA Piper’s global restructuring group.
The European Union member states are preparing to introduce a new European Patent with Unitary Effect and a single Unified Patent Court with divisions located throughout Europe.
California’s Insurance Fraud Prevention Act: three unsettled issues the health sector should understand
California’s Insurance Frauds Prevention Act, Ins. Code §§ 1871 et seq. (IFPA), is an unusual false claims statute.
Patents directed to genetic material have been the subject of significant public discourse and legal challenge worldwide.
A court ruled in the case of a plaintiff who claimed his privacy rights had been violated because Google search engine results of his name included news articles suggesting he had a criminal past.
This briefing from DLA Piper discusses three key intellectual property and technology cases: Kimble v Marvel Enterprises, B&B Hardware, inc v Hargis Industries and Teva Pharmaceuticals v Sandoz.
The Supreme Court ruled in FTC v Actavis that settlement agreements for patent infringement suits between branded and generic drug companies are not immune from antitrust scrutiny.
Arguably, Germany is the jurisdiction that has the most to lose with the introduction of the UPC.
From a foreign perspective, it is not easy to understand the difference between UP and UPC.
While a radical departure from prior practice in the EU, the concept of a European Patent with Unitary Effect will be familiar to US practitioners.
The introduction of a unitary patent and a unified patent court system is viewed as a very exciting prospect.
This year the EU asset-backed securities purchase programme failed to generate enthusiasm, while an EU bond purchase programme continues to be discussed but not delivered.
Extended through the end of this year are a host of tax-related deductions and credits that affect businesses and individuals, among them the work opportunity tax credit.
DLA Piper presents its top five countdown of privacy and cyber predictions and trends and issues for 2015 including the ‘ripple effect’ — the impact of EU data protection regulation.
Health Alert — changes to Commonwealth Seniors Health Card; Cheney v Mid North Coast Local Health District; and more
DLA Piper has released the 15 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The president and key members of his administration have signalled that tax reform is a high priority and one of a short list of legislative accomplishments that he would like to complete during his final two years in office.